As the COVID-19 pandemic continues to spread across the world, reports on the unique experience of COVID-19 in children are starting to emerge. Most recently, a rare, but serious condition has been recognized called Multisystem inflammatory syndrome in children (MIS-C), a complication of Covid-19 infection.
While children were initially thought to be largely spared from Covid-19 most serious effects, new studies highlight the critical need for pediatric research – from treatments to vaccines. Please join Sally Allain, Head of JLABS @ Washington, DC, with Dr. David Wessel, Chief Medical Officer at Children's National Hospital, Dr. Roberta L. DeBiasi, Chief of the Division of Pediatric Infectious Diseases at Children’s National Hospital and Dr. Samuel Maldonado, Head of Pediatric Drug Development and Vice President, Child Health Innovation Leadership Department at Johnson & Johnson. The conversation will focus on the latest Covid-19 pediatric science – and what incentives might speed answers for children, their families and communities through this pandemic and beyond.